Living

July 8, 2013

FDA approves nonhormonal treatment for hot flashes

Prescribed off-label by doctors for years for the treatment of hot flashes in menopausal women, the drug Brisdelle was recently approved by the FDA for that purpose. Brisdelle contains paroxetine, the active ingredient in the antidepressant drug Paxil. A Duke University doctor answers some questions about the drug.

Related content

Comments

Entertainment Videos